DOI: 10.1055/s-00033990

TH Open

References

Bysted BV, Scharling B, Møller T, Hansen BL.
A randomized, double-blind trial demonstrating bioequivalence of the current recombinant activated factor VII formulation and a new robust 25 degrees C stable formulation.

Haemophilia 2007;
13 (05) 527-532

Download Bibliographical Data

Search in:
Access: